Skip to main content

Neonatal Immunization

CBE ID
0485
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
1.3 Measure Description

Percent of neonates with a length of stay greater than 60 days receiving DPT, Hepatitis B, Polio, Hib, and PCV immunizations in adherence with current guidelines.

        • 1.14 Numerator

          Patients from the denominator receiving the following immunizations according to current AAP guidelines:
          • DPT (DTP, DPT, DtaP, DTw-P-HbOC, DTwP-HIB, Acel-Imune, Tripedia, Infanrix, Tetramune [DTPH], Tripedia/ActHIB, TriHIBit, Certiva, Immunol)
          • HepB (Comvax, Recombivax HB, Engerix-B)
          • Polio (IPOL, IPV, OPV, Orimune, Poliovax)
          • Hib (PedvaxHIB, HibTITER, ProHIBit [PRP-D], Tetramune [DTPH], Tripedia/ActHIB, TriHIBit, ActHIB, OmniHIB [PRP-T], Comvax)
          • PCV (Prevnar, Pneumovax, Pnu-Imune).

        • 1.15 Denominator

          Neonates with a length of stay greater than 60 days.

        • Exclusions

          Documented parent refusal and mortalities. The developer recommends that the measure be suspended when there are vaccine shortages rather than including vaccine unavailability as an exclusion.

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Perinatal and Reproductive Health Endorsement Maintenance Project
          Initial Endorsement
          Last Updated
          Removal Date